ArticleCytotherapy2018

Human papilloma virus-specific T cells can be generated from naïve T cells for use as an immunotherapeutic strategy for immunocompromised patients.

Sarah E McCormack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.